Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Monday that its first quarter revenues rose 80 percent, driven in part by continued sales growth of its ePlex molecular diagnostics analyzer and by its SARS-CoV-2 test.

The company also announced interim CEO Scott Mendel had been appointed President and CEO.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.